CVS Health's Q3 earnings topped forecasts with an adjusted EPS of $2.21 and sales of $89.76 billion, a 10.6% YoY increase. The strong results were driven by robust health services revenue, a high-performing pharmacy segment, and a successful cost-cutting strategy. The company also reported a higher Medicare Advantage utilization, reflected in a medical benefits ratio of 85.7%, 100 basis points above consensus. However, a nationwide pharmacist walkout poses a challenge for CVS.
CVS saw sales rise 10.6% YoY with a top and bottom line beat in today's earnings report. However, the company is now facing a nationwide pharmacist walkout. https://t.co/udGAEjegQi
CVS profit beats estimates on strong performance of pharmacy segment https://t.co/OuL4Hx7EaX https://t.co/IkSp6IDXje
$CVS (-4.3% pre) CVS Health earnings top forecasts on pharmacy, health care benefits strength https://t.co/NC6woqtBQ8
CVS results top expectations, lifted by strong health services revenue https://t.co/9g79MihojB
$CVS Q3 $2.21 eps vs $2.13 estimate; Revenues $89.9 B vs. $88.3 B; reaffirms guidance. Medical Benefits Ratio 85.7% 100 bps above consensus, driven by higher Medicare Advantage utilization. https://t.co/4FYD5Bq0mz
CVS results top expectations, lifted by strong health services revenue https://t.co/gGa8fqEonT
CVS Health earnings top forecasts on pharmacy, health care benefits strength https://t.co/auih9b2lbM
CVS posts higher sales and profit in the third quarter, a sign that the drugstore chain’s cost-cutting strategy is paying off https://t.co/jFcZstfKki
$CVS | CVS Health Q3 Earnings: - Adjusted EPS $2.21 (Est. $2.13) - Sales $89.76B (Est. $88.25B)